Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N A Harris

Showing results (11-20 of 200) with videos related to

Pageof 20
Sort By:
Cancer Research|April 1, 1985
Suppression of DNA synthesis in NEL-M1 human melanoma cells by triamcinolone acetonideD M DiSorbo, N A Harris, L Nathanson
Cancer Research|May 1, 1984
Effect of triamcinolone acetonide on tyrosinase activity in a human melanoma cell lineD M DiSorbo, N A Harris, L Nathanson
American Journal of Diseases of Children (1960)|August 1, 1979
Transient respiratory depression of the newborn. Its occurrence after succinylcholine administration to the motherD Hoefnagel, N A Harris, T H Kim
Infectious Diseases (London, England)|October 16, 2018
Infectious complications following transrectal ultrasound-guided prostate biopsy: what additional diagnostic value do blood cultures provide?Vichitra Sukumaran, Matthew J Roberts, Patrick N A Harris
Diagnostic Microbiology and Infectious Disease|April 4, 2024
Proteus species bloodstream infections: Comparative epidemiology of three speciesKevin B Laupland, Felicity Edwards, Patrick N A Harris
Jac-Antimicrobial Resistance|July 5, 2021
PRO: Carbapenems should be used for ALL infections caused by ceftriaxone-resistant EnterobacteralesDavid L Paterson, Burcu Isler, Patrick N A Harris
Pathology|May 5, 2015
Antimicrobial susceptibility reporting and treatment selection for AmpC-producing Enterobacteriaceae: what do microbiologists and infectious disease practitioners actually practice?P N A Harris, L Alder, D L Paterson
Current Opinion in Infectious Diseases|December 14, 2019
Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremiaDavid L Paterson, Andrew Henderson, Patrick N A Harris
Infectious Disease Clinics of North America|December 20, 2025
Rapid Diagnostic Strategies for Antibiotic-Resistant Bacteria Causing Bloodstream InfectionAnna Maria Peri, Patrick N A Harris, Ritu Banerjee
JAMA|February 13, 2019
Antibiotics for Ceftriaxone Resistant Gram-Negative Bacterial Bloodstream Infections-ReplyPatrick N A Harris, Paul Tambyah, David L Paterson
Pageof 20

Showing results (11-20 of 200) with videos related to

Sort By:
Pageof 20
Cancer Research|April 1, 1985
Suppression of DNA synthesis in NEL-M1 human melanoma cells by triamcinolone acetonideD M DiSorbo, N A Harris, L Nathanson
Cancer Research|May 1, 1984
Effect of triamcinolone acetonide on tyrosinase activity in a human melanoma cell lineD M DiSorbo, N A Harris, L Nathanson
American Journal of Diseases of Children (1960)|August 1, 1979
Transient respiratory depression of the newborn. Its occurrence after succinylcholine administration to the motherD Hoefnagel, N A Harris, T H Kim
Infectious Diseases (London, England)|October 16, 2018
Infectious complications following transrectal ultrasound-guided prostate biopsy: what additional diagnostic value do blood cultures provide?Vichitra Sukumaran, Matthew J Roberts, Patrick N A Harris
Diagnostic Microbiology and Infectious Disease|April 4, 2024
Proteus species bloodstream infections: Comparative epidemiology of three speciesKevin B Laupland, Felicity Edwards, Patrick N A Harris
Jac-Antimicrobial Resistance|July 5, 2021
PRO: Carbapenems should be used for ALL infections caused by ceftriaxone-resistant EnterobacteralesDavid L Paterson, Burcu Isler, Patrick N A Harris
Pathology|May 5, 2015
Antimicrobial susceptibility reporting and treatment selection for AmpC-producing Enterobacteriaceae: what do microbiologists and infectious disease practitioners actually practice?P N A Harris, L Alder, D L Paterson
Current Opinion in Infectious Diseases|December 14, 2019
Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremiaDavid L Paterson, Andrew Henderson, Patrick N A Harris
Infectious Disease Clinics of North America|December 20, 2025
Rapid Diagnostic Strategies for Antibiotic-Resistant Bacteria Causing Bloodstream InfectionAnna Maria Peri, Patrick N A Harris, Ritu Banerjee
JAMA|February 13, 2019
Antibiotics for Ceftriaxone Resistant Gram-Negative Bacterial Bloodstream Infections-ReplyPatrick N A Harris, Paul Tambyah, David L Paterson
Pageof 20